KEY FEATURES
| Full Name | Protein Kinase, AMP Activated Alpha 1 |
|---|---|
| Synonym | PRKAa1; AMPK; AMPKa1; PKA; ACACA kinase; 5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-1; Acetyl-CoA carboxylase kinase; Hydroxymethylglutaryl-CoA reductase kinase |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human AMPKAlpha1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human AMPKAlpha1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human AMPKAlpha1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human AMPKAlpha1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human AMPKAlpha1. You can calculate the concentration of Human AMPKAlpha1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human AMPKAlpha1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.51 | 1.43 | 4.37 | 0.49 | 1.47 | 4.15 |
| Standard deviation | 0.03 | 0.08 | 0.22 | 0.03 | 0.08 | 0.13 |
| CV(%) | 6.57 | 5.32 | 4.97 | 6.04 | 5.58 | 3.06 |
RECOVERY
The recovery of Human AMPKAlpha1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-107 | 100 |
| EDTA plasma (n=8) | 88-101 | 95 |
| Cell culture media (n=8) | 93-106 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human AMPKAlpha1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with AMPKalpha1 ELISA Kits
| PRKAA2 ELISA Kit | publications with AMPKalpha1 and PRKAA2 |
| PRKAG1 ELISA Kit | publications with AMPKalpha1 and PRKAG1 |
| PRKAB1 ELISA Kit | publications with AMPKalpha1 and PRKAB1 |
| PRKAB2 ELISA Kit | publications with AMPKalpha1 and PRKAB2 |
| STK11 ELISA Kit | publications with AMPKalpha1 and STK11 |
| PRKAG3 ELISA Kit | publications with AMPKalpha1 and PRKAG3 |
| PRKAG2 ELISA Kit | publications with AMPKalpha1 and PRKAG2 |
| TSC2 ELISA Kit | publications with AMPKalpha1 and TSC2 |
Pathways associated with AMPKalpha1 ELISA Kit
| AMPK Signaling Pathway | AMPK Signaling Pathway |
| Adipocytokine Signaling Pathway | Adipocytokine Signaling Pathway |
| BDNF Signaling Pathway | BDNF Signaling Pathway |
| Circadian Rhythm Pathway | Circadian Rhythm Pathway |
| Energy Metabolism Pathway | Energy Metabolism Pathway |
| Energy Dependent Regulation Of MTOR By LKB1-AMPK Pathway | Energy Dependent Regulation Of MTOR By LKB1-AMPK Pathway |
| Hypertrophic Cardiomyopathy (HCM) Pathway | Hypertrophic Cardiomyopathy (HCM) Pathway |
Diseases associated with AMPKalpha1 ELISA Kit
| Neoplasms | publications with AMPKalpha1 and Neoplasms |
| Cardiovascular Diseases | publications with AMPKalpha1 and Cardiovascular Diseases |
| Death | publications with AMPKalpha1 and Death |
| Heart Diseases | publications with AMPKalpha1 and Heart Diseases |
| Fatty Liver | publications with AMPKalpha1 and Fatty Liver |
| Inflammation | publications with AMPKalpha1 and Inflammation |
| Necrosis | publications with AMPKalpha1 and Necrosis |
| Insulin Resistance | publications with AMPKalpha1 and Insulin Resistance |
| Liver Diseases | publications with AMPKalpha1 and Liver Diseases |
| Nervous System Diseases | publications with AMPKalpha1 and Nervous System Diseases |
Organs/Tissues associated with AMPKalpha1 ELISA Kit
| Muscle | publications with AMPKalpha1 and Muscle |
| Liver | publications with AMPKalpha1 and Liver |
| Blood | publications with AMPKalpha1 and Blood |
| Vascular | publications with AMPKalpha1 and Vascular |
| Adipose Tissue | publications with AMPKalpha1 and Adipose Tissue |
| Brain | publications with AMPKalpha1 and Brain |
| Lung | publications with AMPKalpha1 and Lung |
| Pancreas | publications with AMPKalpha1 and Pancreas |
| Connective Tissue | publications with AMPKalpha1 and Connective Tissue |
| Placenta | publications with AMPKalpha1 and Placenta |